CIK: 1356227 - Address: C/o Xeris Pharmaceuticals, Inc., 180 N. Lasalle Street, Suite 1810, Chicago, IL 60601
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/4/18 19:40
8/30/18
STDYSteadymed Ltd.L3HealthDrugPharmaceutical PreparationsRigby JonathanCADOP,CEOS.d-2084.460-47-1000M
8/27/18 16:07
8/23/18
STDYSteadymed Ltd.L3HealthDrugPharmaceutical PreparationsRigby JonathanCADOP,CEOM.dm1682.7406142D
8/27/18 16:07
8/23/18
STDYSteadymed Ltd.L3HealthDrugPharmaceutical PreparationsRigby JonathanCADOP,CEOS.dm-2894.720-61-6042D
8/17/18 16:05
8/17/18
STDYSteadymed Ltd.L3HealthDrugPharmaceutical PreparationsRigby JonathanCADOP,CEOS-4144.660-89-6647D
8/10/18 16:22
8/9/18
STDYSteadymed Ltd.L3HealthDrugPharmaceutical PreparationsRigby JonathanCADOP,CEOM.d3213.61089191135D
7/3/18 14:39
7/2/18
STDYSteadymed Ltd.L3HealthDrugPharmaceutical PreparationsRigby JonathanCADOP,CEOS-2104.500-47-5047M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact